Cite
HARVARD Citation
Boland, K. et al. (n.d.). A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers. Human psychopharmacology. p. n/a. [Online].